Home > Boards > US OTC > Cannabis > Cannabis Science, Inc. (CBIS)

People need to read this quote from the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
PeytonCom Member Profile
 
Followed By 0
Posts 76
Boards Moderated 0
Alias Born 02/02/10
160x600 placeholder
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/17/2015 4:51:33 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 7/28/2015 1:01:54 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/30/2015 6:06:54 AM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 6/18/2015 6:35:38 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 6/18/2015 6:30:37 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 6/18/2015 6:24:46 PM
Amended Statement of Beneficial Ownership (3/a) "Edgar (US Regulatory)" - 6/18/2015 6:03:44 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/16/2015 5:45:25 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 6/11/2015 1:48:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/10/2015 6:54:28 PM
Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro®,... "PR Newswire (US)" - 5/27/2015 8:05:00 AM
OmniCanna (ENDO) Today Launches www.TheHempery.com "Specialized Hemp Based Health and Wellness" Online Store "PR Newswire (US)" - 5/20/2015 9:12:00 AM
CBIS Expands Licensing Deal with Purple Haze Properties as it Launches 'Jimi's Cannabis Collection' Today at the Chicago 'Mar... "PR Newswire (US)" - 5/19/2015 10:42:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/18/2015 4:53:04 PM
OmniCanna Health Solutions, Inc. (ENDO) Names Greta Gaines as CEO & President as Company Prepares for US Release of 'The Hemp... "PR Newswire (US)" - 5/18/2015 9:18:00 AM
Cannabis Science Acquires Pet Care Manufacturer and Distributor Equi-Pharm & Enters the $60 Billion Pet Care Industry "PR Newswire (US)" - 5/7/2015 12:58:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/29/2015 5:52:09 PM
Cannabis Science (CBIS) Accepted To Present at ICAR 2015 "PR Newswire (US)" - 4/22/2015 8:27:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/21/2015 2:50:13 PM
Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom "PR Newswire (US)" - 4/2/2015 12:51:00 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 4/1/2015 2:29:26 PM
Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives "PR Newswire (US)" - 3/31/2015 8:37:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 5:17:02 PM
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest "PR Newswire (US)" - 3/26/2015 10:09:00 AM
PeytonCom   Thursday, 03/17/11 01:11:30 PM
Re: MadHatter326 post# 20181
Post # of 114146 
People need to read this quote from the PR, CBIS has some incredible potential with proper exposure:

"To date, we have already partnered with the University of California Irvine Medical Center to oversee our cannabis-based Autism research. Included in this group of advisors is the Dean of Medicine at UCI, and child psychiatrist Dr. Rebecca Hedrick M.D. Dr. Melamede of Cannabis Science will be an outstanding addition to the Board of the Foundation. His extensive knowledge of cannabinoid science should prove invaluable in our mission.”


Medical doctors don't put their professional reputation on the line for just anyone. If they are on board with CBIS and Dr. Bob, so am I.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist